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Abstract
Background: The primary olfactory pathway is a potential route through which microorganisms from the periphery
could potentially access the central nervous system. Our previous studies demonstrated that if the olfactory
epithelium was damaged, bacteria administered into the nasal cavity induced nitric oxide production in olfactory
ensheathing cells. This study investigates the cytokine profile of olfactory tissues as a consequence of bacterial
challenge and establishes whether or not the bacteria are able to reach the olfactory bulb in the central nervous
system.
Methods: The olfactory epithelium of C57BL/6 mice was damaged by unilateral Triton X-100 nasal washing, and
Staphylococcus aureus was administered ipsilaterally 4 days later. Olfactory mucosa and bulb were harvested 6 h,
24 h and 5 days after inoculation and their cytokine profile compared to control tissues. The fate of S. aureus and
the response of bulbar microglia were examined using fluorescence microscopy and transmission electron
microscopy.
Results: In the olfactory mucosa, administered S. aureus was present in supporting cells of the olfactory epithelium,
and macrophages and olfactory nerve bundles in the lamina propria. Fluorescein isothiocyanate-conjugated
S. aureus was observed within the olfactory mucosa and bulb 6 h after inoculation, but remained restricted to the
peripheral layers up to 5 days later. At the 24-h time point, the level of interleukin-6 (IL-6) and tumour necrosis
factor-α in the compromised olfactory tissues challenged with bacteria (12,466 ± 956 pg/ml and 552 ± 193 pg/ml,
respectively) was significantly higher than that in compromised olfactory tissues alone (6,092 ± 1,403 pg/ml and
80 ± 2 pg/ml, respectively). Immunohistochemistry confirmed that IL-6 was present in several cell types including
olfactory ensheathing cells and mitral cells of the olfactory bulb. Concurrently, there was a 4.4-, 4.5- and 2.8-fold
increase in the density of iNOS-expressing cells in the olfactory mucosa, olfactory nerve and glomerular layers
combined, and granule layer of the olfactory bulb, respectively.
Conclusions: Bacteria are able to penetrate the immunological defence of the compromised olfactory mucosa and
infiltrate the olfactory bulb within 6 h even though a proinflammatory profile is mounted. Activated microglia may
have a role in restricting bacteria to the outer layers of the olfactory bulb.
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Background
The primary olfactory pathway represents a one-synapse
route spanning the olfactory mucosa and the olfactory
bulb. Normally, microbes are prevented from infecting
the olfactory mucosa through sneezing, clearing of mu-
cous, immune responses by cells in the nasal mucosa or
apoptosis of infected cells [1,2]. Though generally suc-
cessful, these protective strategies are known to fail
under certain conditions. Viruses injected into the nasal
cavity have been found to enter olfactory neurons, repli-
cate, travel into the olfactory bulb and then into the cen-
tral nervous system (CNS) [3,4]. In addition, viruses in
circulation can also cross from capillaries in the lamina
propria into olfactory neurons. Because of the close
proximity and the synaptic connections between the
nasal cavity and the CNS, the brain can potentially be
infected in relatively short periods of time [3]. Ginkel
and co-workers demonstrated that intranasal injection of
a strain of Streptococcus pneumonia, which is non-viable
in the blood system, resulted in olfactory bulb and CNS
infection via olfactory axonal transport after just 24 h
[5]. The infection of olfactory neurons was thought to be
through pneumococci interaction with gangliosides
expressed on the cell membranes. The rarity of these
infections suggests that a robust endogenous immuno-
logical defence is likely to be present in olfactory tissues,
but this immunological response has been poorly
studied.
In a recent study, we showed that the intact olfactory
epithelium was an effective barrier in preventing the in-
filtration of Staphylococcus aureus into the nasal lamina
propria [6]. However if the olfactory epithelium was
damaged by zinc sulphate or Triton-X irrigation, it was
susceptible to bacterial infiltration, and this led to the
appearance of inducible nitric oxide synthase (iNOS)-
expressing cells in the lamina propria, some of which
were the neuroglia of olfactory nerves, the olfactory en-
sheathing cells (OECs) [6]. Consistent with this finding,
nitric oxide production by OECS was demonstrated
within 1 h of bacterial exposure in vitro [6]. Further-
more, microarray analysis showed that OECs have
enriched transcripts for the chemokines CXCL1 and
MCP-1 [7], both of which increased when OECs were
exposed to Escherichia coli and S. aureus in vitro [8].
CX3CL1, a cytokine known to influence the migration of
CX3CR1-positive innate immune cells into tissue [9], is
also expressed by olfactory neurons and OECs [10].
Thus, the evidence suggests the existence of an immune
barrier in the nasal cavity that is contributed in part by
OECs.
This study aims to build on these previous findings
and obtain new knowledge about the immunological sta-
tus of the olfactory mucosa and bulb. We investigated
the cytokine and macrophage profile of damaged
olfactory tissues in response to bacterial challenge and
tracked the infiltration of bacteria into the olfactory
bulb.
Methods
All experiments involving animals in this project were
approved by the Animal Experimentation Ethics Com-
mittee of the University of Tasmania and are consistent
with the Australian Code of Practice for the Care and
Use of Animals for Scientific Purpose. mice aged 6–
7 weeks were maintained on a 12-h light:dark cycle in
filtered, sterile air by the Menzies Research Institute
Animal Services.
S. Aureus cultures and fluorescein isothiocyanate (FITC)
conjugation
A loopful from slope cultures of S. aureus (ATCC
33862) (kindly donated by the Microbiology Department
of the University of Tasmania) was streaked onto nutri-
ent agar plates and incubated overnight at 370 C. Single
colonies were then picked and inoculated into 1 ml L-
broth cultures (pH 7.2) and incubated overnight at
370 C, shaking at 300 rpm in an orbital shaker (Ratek
Instruments, Australia). Bacteria from tubes that exhib-
ited growth, as evidenced by turbidity of broth, were
inoculated directly into the left nasal cavity of mice in
the appropriate treatment group at the designated time
points.
In order to visually localise bacteria under fluorescence
microscopy, S. aureus was conjugated to FITC by incu-
bating 10 μl FITC (1 mg/ml; Sigma Aldrich, Australia)
in 1 ml L-broth and S. aureus at 370 C for 1.5 h. The
culture was then washed with 500 μl filtered PBS and
centrifuged at 12,000 rpm for 30 s. The supernatant was
removed, and the pellet washed twice and resuspended
in 200 μl filtered PBS prior to nasal inoculation. Follow-
ing FITC conjugation, random samples of S. aureus were
checked on the fluorescence microscope to confirm that
conjugation was successful (Figure 1A). In addition,
some were plated on nutrient agar plates and left over-
night at 370 C. Growth was typically observed, indicating
Figure 1 S. aureus conjugated with FITC prior to inoculation in
the nasal cavity (A); S. aureus conjugated with FITC and
cultured on nutrient agar plates overnight, confirming viability
and continued fluorescence (B). Scale bar=10 μm.
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viable bacteria as well as continued fluorescence
(Figure 1B).
Cytokine assay of olfactory tissues
Animals were divided into four groups: (1) untreated
mice (NT); (2) mice treated with 30 μl 1% Triton X-100
alone (TX); (3) mice treated with 30 μl 1% Triton X-100
and 30 μl 0.9% sterile saline 4 days later (TXS); (4) mice
treated with 30 μl Triton X-100 and 30 μl S. aureus
4 days later (TXB). The amount of S. aureus inoculated
into the nasal cavity was equivalent to 3 x 107. Bacteria
were introduced 4 days after Triton X-100 washing be-
cause at this time most of the damaged olfactory neu-
rons have sloughed off while the basal cells have
initiated proliferation to reconstitute the epithelium [11].
Nasal irrigation was performed unilaterally on the left
side of the nasal cavity using 30-gauge plastic tubing
attached to the end of a 29-G needle. Mice were lightly
anaesthetised with 0.6% isoflurane in air prior to Triton
X-100, saline or S. aureus inoculation.
Mice of the TX group were perfused 4 days after Tri-
ton X-100 irrigation; mice of the TXS and TXB groups
were perfused either 6 h (TXS6, TXB6 respectively) or
24 h (TXS24, TXB24 respectively) after saline or S. aur-
eus inoculation. Mice were euthanised with sodium
pentobarbitone (50 mg/kg i.p.) before transcardial perfu-
sion with chilled phosphate-buffered saline (PBS) in an
aseptic environment. The olfactory bulbs, olfactory tur-
binates and septum were dissected. Tissue from each
group was pooled, minced and homogenised in lysis buf-
fer (catalogue no. 0103004-L; RayBioTech) with 3% pro-
tease inhibitor. Samples were centrifuged at 13,000 g for
10 min at 4 °C. The supernatant and pellet were sepa-
rated, snap frozen in liquid nitrogen and stored at −80 °
C until use in cytokine assay.
A modified Bradford assay [12] was carried out to es-
tablish the total protein concentration of the pooled ol-
factory tissue supernatant from each treatment group.
This was done in order to estimate the correct sample
amount to be used in the cytokine arrays. One part
Bradford reagent was diluted for four parts distilled
water. Standard protein samples at concentrations of 0.1,
0.15, 0.2, 0.25, 0.5 and 1.0 mg/ml were prepared using
DNase free bovine serum albumin. Each standard was
diluted 1:50 using Bradford reagent in a 96-well plate.
Samples were diluted 1:100 in MilliQ water and then
further diluted 1:100 in a 96-well plate using Bradford
reagent. Replicates were made of each standard and
sample. Absorbance at 595 nm was measured using a
Tecan GENios microplate reader and analysed using the
XFluor4 (v.4.5) software. From measured absorbance of
standards, a standard curve was created and used to de-
termine the concentration of the samples.
Cytokine assay was performed as three separate
experiments for each time point. For each time point,
tissue was pooled from three untreated mice and four
mice from each of the treated groups (TX, TXS and
TXB) and samples diluted to a concentration of 25 mg/
ml. Cytometric Bead Array Mouse Th1/Th2/Th17 Cyto-
kine Kit (BD Biosciences) detects seven cytokines (inter-
feron-γ, interleukin-10, interleukin-17A, interleukin-2,
interleukin-4, interleukin-6, tumour necrosis factor-α)
using flow cytometry. The assay was run according to
the manufacturer’s instructions. Replicates were run on
a BD FACS Canto II flow cytometer with 2,100 events
measured in the P1 gate, and total events were also
recorded. FCAP array (v1.0.1) software was used to ana-
lyse data collected from the flow cytometer. Raw data
from the BD array were multiplied by the appropriate di-
lution factor to calculate the true concentration of cyto-
kines. Cytokine concentrations for the BD array were
tabulated, and data analyses were conducted using single
factor ANOVA and pairwise multiple comparison
(Tukey test). A p value equal to or less than 0.05 was
considered statistically significant.
Visualisation of FITC-conjugated S. aureus and
immunohistochemical staining for interleukin-6 (IL-6)
A total of 30 μl of S. aureus was inoculated into the left
nasal cavity of eight 6–7-week-old C57/BL6 male mice
that had previously undergone unilateral nasal washing
with 1% Triton-X 100 solution. Mice were killed at 6 h
(n= 3), 24 h (n= 2) and 5 days (n= 3) after inoculation.
Transcardial perfusion was conducted with chilled PBS
followed by Zamboni’s fixative (ZF; 15% picric acid +
0.85% paraformaldehyde). Mice were decapitated and
excess tissue trimmed away, leaving the olfactory bulbs
and nasal cavity en bloc; they were then stored in ZF at
4 °C. Tissue was washed with PBS several times after 2–
3 days to remove ZF before being transferred to 0.01%
azide in PBS. The nasal cavity and olfactory bulb en bloc
were decalcified in clinical fast decal fluid (Lomb Scien-
tific) for 1–1.5 h. Specimens were washed with distilled
water, trimmed and cryoprotected by transferring to 10%
sucrose overnight, followed by 30% sucrose. They were
then frozen in cryomatrix, sectioned at 10 μm in the
horizontal plane using a cryostat (Leica DM-1850),
placed onto SuperFrost Plus slides (Menzel Glaser, Ger-
many) and stored at -200 C. Unstained sections from all
animals were examined on an Olympus BX50 fluores-
cent microscope to localise FITC-conjugated S. aureus.
For immunohistochemical detection of IL-6, sections
were post-fixed with 4% paraformaldehyde for 5 min,
washed for 5 min in PBS and then incubated with 10%
hydrogen peroxide to quench endogenous peroxidase.
Slides were then incubated with Mouse on Mouse block-
ing reagent from the Vector M.O.M Kit for 1 h. They
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were then incubated with Mouse on Mouse diluent from
the M.O.M Kit for 5 min. Sections were incubated with
primary antibody rat anti- IL-6 (1:100; Invitrogen) over-
night at 40 C. Control sections were incubated overnight
with diluent alone or isotype control. Next, sections
were incubated with biotinylated goat anti-rat antibody
(1:1;000, Molecular Probes) for 1 h followed by incuba-
tion with streptavidin conjugated to HRP for 30 min,
and DAB-chromogen solution for 5 to 6 min. Sections
were counterstained with Nuclear Red in 0.03% azide for
1.5 min, coverslipped and viewed on a Leica DM-2500
light microscope. Control sections did not show positive
immunoreactivity.
Olfactory ensheathing cell culture and immunostaining
for IL-6
Olfactory ensheathing cells were isolated from the olfac-
tory nerve layer of the olfactory bulb and the olfactory
mucosa of 3-day-old mouse pups as described in a previ-
ous study [13]. Briefly, the olfactory bulbs and mucosa
were dissected and digested for 20 min using 0.25% tryp-
sin in MEM-H (Gibco) at 37 °C. Dulbecco’s modified
Eagle’s medium with HEPES (DMEM-H; Gibco) supple-
mented with 10% foetal calf serum (DMEM-10FCS) was
added to terminate digestion, and the suspension was cen-
trifuged at 500 g for 10 min. The supernatant was
removed and the pellet resuspended in DMEM-H. Cells
were dissociated and plated onto acid-washed 13-mm
coverslips coated with 4% poly-L-lysine. Following incu-
bation for 24 h at 37 °C, cytosine-β-D-arabinofuranoside
(100 μM) was added and cells were incubated for another
2 days at 37 °C until cultures were sufficiently free of
contaminating cells. The medium was then replaced with
fresh DMEM- 10FCS supplemented with bovine pituitary
extract (50 μg/ml; Sigma) to allow cellular expansion.
Cultures yielded 95% OECs based on positive immunor-
eactivity with anti-p75NTR.
The immunostaining procedure for IL-6 was similar to
that used on tissues sections, except that cultures were
treated with a shorter incubation time (1 h) with the pri-
mary antibody. Cells were counterstained with Nuclear
Red in 0.03% azide for 1 min, dehydrated and mounted
with DPX.
Immunofluorescent staining with Iba1, anti-iNOS and
tomato lectin, and quantitative analysis
The left nasal cavity of six 6–7-week-old C57/BL6 male
mice that had previously undergone unilateral nasal
washing with 1% Triton-X 100 solution was inoculated
with 30 μl of S. aureus (3 mice) or saline (3 mice). The
mice were euthanised with sodium pentobarbitone
(50 mg/kg i.p.) at 24 h after bacterial inoculation and
transcardially perfused with chilled PBS followed by 4%
paraformaldehyde. For comparison, three untreated 6–7-
week-old C57/BL6 male mice were also killed and trans-
cardially perfused. Mice were decapitated, and the heads
trimmed and processed for cryosectioning, as described
for immunohistochemistry in the preceding section.
Ten-micron-thick sections were post-fixed with 4% par-
aformaldehyde for 15 min, washed gently three times
with PBS and blocked using Dako Protein Block Serum-
free (DakoCytomation) for 5 min prior to incubation
with primary antibodies. Microglia were identified by
positive immunoreactivity for Iba1 or binding to tomato
lectin [14,15]. In single labelling, sections were incubated
with rabbit-anti iNOS/NOS type II (1:400; BD Bios-
ciences), Iba1 (1:200; Wako) or biotinylated tomato lec-
tin (10 μg/ml diluted 1:200; Vector Labs) for 2 h. This
was followed by incubation with goat anti-rabbit Alexa-
Fluor 594 (1:1,000; Molecular Probes), goat anti-mouse
AlexaFluor 488 (1:1000; Molecular Probes) or streptavi-
din AlexaFluor 488 (1:1000; Molecular Probes) respect-
ively for 1 h at room temperature in the dark, followed
by 0.0001% Nuclear Yellow (Sigma) staining for 5 min
prior to mounting and storage at 40 C. In some sections,
double labelling with Iba1 and tomato lectin was done
to ascertain colocalisation. Double labelling with anti-
iNOS and tomato lectin was also done to identify iNOS-
producing microglia.
Nine separate frames, taken with 40× objective, cap-
turing the olfactory nerve and glomerular layers of the
rostral part of the olfactory bulb from each animal were
used in the cell counts of iNOS- and Iba1-positive cells.
Cell counts and epithelial distance, as represented by the
basal lamina, were measured using Image J. The data
were analysed by two-way ANOVA and pairwise mul-
tiple comparison (Tukey test). A p value equal to or less
than 0.05 was considered statistically significant.
Transmission electron microscopy
Six mice were subjected to unilateral nasal wash with 1%
Triton-X 100 solution and 4 days after received 30 μl of
live S. aureus in the ipsilateral nasal cavity. Six and 12 h
after bacterial inoculation, mice were perfused with
chilled PBS followed by 2.5% glutaraldehyde in 0.2 M
cacodylate buffer. The nasal septum was dissected,
immersed in 2.5% glutaraldehyde overnight at 40 C and
processed according to methods established previously
in our laboratory [16]. The following day specimens
were washed in 0.1 M cacodylate buffer, post-fixed in 1%
osmium tetroxide (2 h), rinsed in cacodylate buffer and
stained in saturated uranyl acetate in 50% ethanol for
10 min. Next, specimens were washed and dehydrated in
an increasing series of ethanols (70–100%). Specimens
were cleared in three changes of propylene oxide and
immersed overnight in a 1:4 mix of propylene oxide and
Procure 812 resin. Specimens were then transferred to
BEEM capsules and embedded in Procure 812 resin in a
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600 C oven for 48 h. Thick (1 μm) and ultrathin (70–
90 nm) sections were cut using a Leica ultramicrotome
and placed on formvar-coated copper palladium grids
(ProSciTech, Qld). Thin sections were stained with satu-
rated uranyl acetate in 5% ethanol (30 min) followed by
lead citrate (5 min) prior to being viewed on a Philips
CM100 transmission electron microscope.
Results
Olfactory tissues damaged by Triton-X 100 significantly
upregulate the expression of IL-6 and TNF-α when
exposed to bacteria
Triton X-100 was used in this study because its cellular
effects are well characterised [11,17]. It selectively
destroys mature olfactory neurons and leaves the rest of
the olfactory mucosa intact with no direct damage to the
olfactory bulb. In the normal olfactory mucosa and bulb
there was negligible expression of IL-6 (26 ± 7 pg/ml)
(Figure 2A). Olfactory epithelial ablation by Triton-X 100
induced expression of IL-6, which was measured 4 days
later (3,309±1,052 pg/ml; p< 0.01). When this damaged
olfactory mucosa was exposed to S. aureus, a further sig-
nificant upregulation of IL-6 was observed 24 h later
(12,466±956 pg/ml). This was also significantly higher
than that of similarly ablated olfactory tissues subjected
to saline wash at the 24-h time point (6,092± 1,403 pg/ml;
p< 0.05). No significant difference between these two
treatment groups (p=0.26) was detected at the 6-h time
point. There was no significant difference in IL-6 con-
centration between the TX (3,309± 1,052 pg/ml) and
TXS groups (6 h= 3,748± 1,086 pg/ml, p=0.80; 24 h=
6,092± 1,403 pg/ml, p=0.15), suggesting that nasal wash-
ing per se did not induce IL-6 upregulation.
Immunohistochemical staining showed that IL-6 was
present in the apical region of sustentacular cells in the
olfactory epithelium, as well as in cells throughout the
Figure 2 Measurement of interleukin-6 (IL-6; A) and tumour necrosis factor-α (TNF-α; B) in groups of mice: untreated (NT); unilateral
nasal wash with Triton X-100 alone (TX); unilateral nasal wash with Triton X-100 followed by saline wash (TXS); unilateral nasal wash
with Triton X-100 followed by S. aureus inoculation (TXB). Undamaged normal olfactory tissues express negligible amounts of IL-6 and TNF-α.
At 4 days post-Triton X-100 damage (TX), olfactory tissues had an initial expression of IL-6 and TNF-α of 3,309 ± 1,052 pg/ml and 49± 6 pg/ml
respectively. The level of IL-6 is significantly increased by the presence of bacteria at the 24-h time point (12,466 ± 956 pg/ml). The upregulation
of IL-6 appears to follow that of TNF-α, which occurs at the 6-h time point, albeit at a lower concentration (1,024 ± 137 pg/ml). Thereafter, at the
24-h time point, a decreasing trend in TNF-α production is observed. Error bars represent SEM. *p< 0.05; **p< 0.01. IL-6 expression in the
olfactory mucosa (C) and olfactory bulb (D) 24 h post-inoculation with S. aureus. IL-6 immunoreactivity is present in the cytoplasm of select
groups of supporting cells in the apical part of the olfactory epithelium (OE). Some cells straddling the OE and lamina propria (LP), possibly OECs
or macrophages, express IL-6 (large arrow), while others do not (small arrow). Several cells in the LP are immunopositive for IL-6 including some
that surround the small lumen (arrowheads), which are most likely endothelial cells or inflammatory cells. Inset shows immunoreactivity for IL-6 in
cultured OECs. White arrowhead at the edge of the micrograph indicates location of basal lamina. In the olfactory bulb mitral cell soma (arrows)
show positive immunostaining for IL-6 with more diffuse staining in the external plexiform layer (EPL). GrL=granule cell layer; scale bar= 40 μm
(inset in C); 50 μm (C,D).
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lamina propria (Figure 2C), some of which could be
OECs or infiltrating immune cells. IL-6-positive cells
that straddled the olfactory epithelium and the lamina
propria are consistent with OECs as they emerge from
the olfactory epithelium to accompany differentiating
axons [18]. Alternatively they could be macrophages that
reside in the olfactory epithelium [10]. Other IL-6-
positive cells within the lamina propria appeared to sur-
round blood vessels, and these cells could either be
endothelial cells or infiltrating inflammatory cells. Subse-
quent isolation of OECs from the olfactory mucosa and
bulb, and cell culture confirmed that OECs expressed
IL-6 (inset in Figure 2C). In the olfactory bulb, immu-
nostaining for IL-6 was observed in the external plexi-
form layer and mitral cells (Figure 2D) and less intensely
in the glomerular and olfactory nerve layer.
At 4 days post-injury with Triton X-100, olfactory tis-
sues showed an initial level of 49 ± 6 pg/ml TNF-α,
which increased significantly to 1,024 1 ± 37 pg/ml 6 h
after S. aureus exposure (p< 0.01) (Figure 2B). In com-
parison, Triton X-100 damaged olfactory tissues exposed
to saline alone yielded 108 ± 4 pg/ml TNF-α. There was
no significant difference (p= 0.10) in the TNF-α re-
sponse to bacteria between 6 and 24 h (552 ± 193 pg/
ml), although there appeared to be a downward trend.
TNF-α concentration at both 6 and 24 h after S. aureus
inoculation remained significantly higher when com-
pared to the saline control (6 h = 108 ± 4 pg/ml, p< 0.01;
24 h = 80 ± 2 pg/ml, p< 0.05).
Significant differences among treatment groups were
only observed in IL-6 and TNF-α expression. Concentra-
tions of IFN-γ, IL-10, IL-17A, IL-2 and IL-4 were all at
or below the theoretical limit of detection of the BD
array in all groups (data not shown).
FITC-conjugated S. aureus are localised in the olfactory
mucosa and periphery of the olfactory bulb
At 6 and 24 h after bacterial inoculation into the Triton-
X 100 washed nasal cavity, FITC-labelled S. aureus could
be localised to both the olfactory mucosa and bulb
(Figure 3A-C). In the olfactory mucosa, FITC labelling
was observed mainly in the olfactory epithelium and in
rare instances in nerve bundles within the lamina pro-
pria. In the olfactory bulb, fluorescence was observed in
the glomerular and olfactory nerve layers. The aggre-
gates of punctate fluorescent label observed in the olfac-
tory bulb (inset in Figure 3C) suggested that the S.
aureus was most likely to be intracellular. The majority
of fluorescent labels were found on the ipsilateral side of
bacterial inoculation, although some could be found in
the glomerular and olfactory nerve layer of the contralat-
eral bulb (Figure 3D). On the whole, the number of
FITC-labelled S. aureus localised to olfactory tissues was
relatively low. Numerous FITC-labelled S. aureus were
located near the nares at 6 h (Figure 3E), suggesting that
a large number of bacteria were being expelled. Five days
after bacterial inoculation, some FITC- labelling
remained in the olfactory mucosa, the olfactory nerve
and glomerular layers of the ipsilateral olfactory bulb
(Figure 3F). At no time was FITC labelling observed in
the deeper layers of the olfactory bulb.
Transmission electron microscopy of S. aureus in
olfactory mucosa
Ultrastructural observations at the 6- and 24-h time
points yielded similar results. Up to 24 h after inocula-
tion of S. aureus into the nasal cavity previously washed
with Triton-X 100, some bacteria remained on the sur-
face of the epithelium (Figure 4A). The junctional com-
plex between supporting cells remained intact and no
bacteria were observed extracellularly in the olfactory
epithelium. This suggested that S. aureus was unlikely to
have accessed the lamina propria via spaces between
epithelial cells. Instead, endocytosed S. aureus was loca-
lized either in vesicles or in the cytosol of supporting
cells (Figure 4B). Highly vesiculated cells resembling
macrophages were observed straddling the olfactory epi-
thelium and lamina propria (Figure 4C), some of which
in the lamina propria were shown to have endocytosed
bacteria (inset in Figure 4C). S. aureus was present in a
small number of axon bundles (Figure 4D), most likely
olfactory rather than trigeminal nerves given that the
axons were all unmyelinated.
Number of iNOS-positive cells in the olfactory mucosa
and bulb is increased significantly following exposure to
S. aureus
Given that FITC-conjugated S. aureus waspresent in the
glomerular layer of the olfactory bulb 24 h after bacterial
exposure, quantitative analysis was conducted to estab-
lish whether this process induced nitric oxide produc-
tion in the related regions. Although a previous study
from our laboratory showed that some OECs in the lam-
ina propria were induced to express iNOS in response to
bacterial exposure, we did not quantify the relative in-
crease of iNOS-expressing cells or the contribution of
macrophages to the iNOS-expressing population [6].
Here we show that the number of iNOS-positive cells in
the olfactory mucosa and bulb was significantly
increased following bacterial exposure (p=0.01; Figure 5A
and 6A). The density of iNOS-positive cells increased 4.4
fold (from 28±2 to 129±10 cells/mm mucosa) in the ol-
factory mucosa, 4.5 fold (from 468±46 to 2,102±196
cells/mm2) in the olfactory nerve and glomerular layers,
and 2.8 fold (from 403± 21 to 1,113± 181 cells/mm2) in
the granule cell layer. In the damaged olfactory mucosa
exposed to S. aureus, iNOS-positive cells were present
predominantly in the lamina propria close to the olfactory
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epithelium (Figure 5B). About 62% of these cells were
positively immunolabeled with Iba1 (Figure 5A, 5C), indi-
cating that they were macrophages present either in the
lamina propria or olfactory epithelium (Figure 5), while
the rest were likely to be OECs, as demonstrated in our
previous study [6]. Although the density of activated cells,
Figure 3 (A) Line drawing of transverse section of olfactory bulbs and mucosa shows the locations from which micrographs (B-E) were
obtained. At 6 h post-inoculation, FITC-conjugated bacteria (arrows) are present in the olfactory epithelium (OE) and olfactory nerve bundles (NB)
in the lamina propria (LP; B) and in the olfactory nerve layer (ONL) and glomerular layer (GmL) of the olfactory bulb (C). Inset in c shows
aggregates of bacteria. At 24 h post-inoculation, there appear to be more FITC-conjugated bacteria in the ONL and GmL of the treated side with
the corresponding layers of the untreated side (ONL/NT, GmL/NT) showing the presence of a small number of bacteria (D). Numerous FITC-
conjugated S. aureus were located near the nares (E). At 5 days post-inoculation, FITC-conjugated bacteria are restricted largely to the ONL (F).
NC=nasal cavity; EPL= external plexiform layer. Scale bar= 200 μm (B,C,D,F), 500 μm (E), 100 μm (inset in C)
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as represented by iNOS-immunoreactivity, was signifi-
cantly increased in the S. aureus-treated tissue, the density
of macrophages was not significantly increased compared
to untreated tissue (Figure 5A).
In the olfactory bulb, there was also a general increase
in the density of iNOS-expressing cells in the S. aureus-
treated mice, as shown by the quantitative analysis done
on the olfactory nerve, glomerular and granule cell
layers (Figure 6A). Although no significant increase in
Iba1-positive cells was observed in the olfactory bulb,
they had an activated morphology, as evidenced by the
hypertrophied cell bodies and ramified processes. Fur-
ther confirmation that the Iba1-positive cells were
microglia was provided by their positive binding to to-
mato lectin with variable intensities (Figure 6B, C). In
the S. aureus-exposed olfactory bulbs, iNOS-expressing
Figure 4 Ultrastructural distribution of S. aureus 6 h following nasal inoculation. Bacteria (black arrows) are present on the surface of the
epithelium. Junctional complex (white arrow) between supporting cells (SC) remain intact (A). Bacteria may be located in the cytosol (arrows; B) or
within vacuoles of supporting cells (arrowheads; inset in B). Highly vesiculated cells resembling macrophages are observed straddling the olfactory
epithelium (OE) and lamina propria (LP; C). Bacteria are present in the vesicles of some macrophages in the lamina propria (arrows in inset of C) or
more rarely in olfactory nerve bundles (arrows) that are comprised of large (L) and small (S) unmyelinated axons enveloped by cytoplasmic
processes of olfactory ensheathing cells (D). Scale bar= 2 μm (A,B,C,D); 6 μm (inset in C)
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microglia were present not just in the peripheral layers,
but also in the vicinity of the mitral cell layer (Figure 6D).
In comparison, saline-treated olfactory bulbs generally
showed sparse or no immunoreactivity for iNOS
(Figure 6E), similar to untreated olfactory bulbs (data
not shown).
Discussion
This study demonstrates that damage to the olfactory
epithelium compromises the protective barrier and
allows bacteria to gain access to the outer layers of the
olfactory bulb as rapidly as 6 h following exposure. Infil-
tration of S. aureus into the nasal tissues is accompanied
by upregulation of IL-6, TNFα and iNOS expression. In
the olfactory mucosa the cellular immune defence is
provided by macrophages and olfactory ensheathing
cells, while microglia constitute the major defensive cell
in the olfactory bulb. S. aureus is restricted to the
olfactory nerve and glomerular layers of the olfactory
bulb up to 5 days after bacterial exposure.
Biological significance of cytokines in the immune
response of olfactory tissue
Cytokines are humoral components in innate immunity
that are vital in the initiation and regulation of an appro-
priate immune response [19]. In this study expression of
IL-6 and TNF-α was found to significantly increase at
both 6 and 24 h after bacterial inoculation in mice
whose olfactory epithelium had been previously
damaged. The results are consistent with an earlier study
in which elevated IL-6 and TNF-α mRNA levels in the
murine olfactory mucosa and bulb were demonstrated at
24 h following intranasal inoculation with Satratoxin G,
a mycotoxin that damages the olfactory epithelium [20].
Signalling via cytokines such as IL-6 and TNF-α, pro-
duced by macrophages as a result of bacterial detection,
has been shown to be vital in the initiation of immune
responses to directly remove the infecting agent [21,22].
TNF-α, being a pro-inflammatory cytokine, induces a
number of different responses that can potentially ex-
acerbate tissue damage. However, without it, brain
abscesses induced by S. aureus persist, as evidenced by
increased bacterial burdens [23]. Therefore, tight regula-
tion of TNF-α expression needs to occur to maintain a
balance between destruction of normal tissue and re-
moval of potentially devastating bacteria. Pituitary ad-
enylate cyclase-activating peptide (PACAP) is a protein
that is produced by OECs and supporting cells of the ol-
factory epithelium [24] that has been shown to protect
against TNF-α induced cell death in olfactory neurons
[25]. It is possible that PACAP is produced locally by ol-
factory ensheathing cells and sustentacular cells in order
to mitigate the damaging effects of TNF-α in the process
of bacterial elimination. Furthermore the IL-6 receptor
is known to be expressed transiently by OECs following
neuronal cell death in response to bulbectomy [26], sug-
gesting that it may be a primary target of IL-6, including
that produced by OECs themselves. IL-6/IL-6R binding
in OECs may be protective by inducing nuclear trans-
location of STAT transcription pathways, thereby acti-
vating anti-apoptotic pathways [27]. The survival of
OECs would have particular importance in compro-
mised olfactory tissue as these cells have a vital contri-
bution to olfactory neuronal regeneration and innate
immunity [28,29].
Studies on macrophages and OECs have shown that
NFκB nuclear translocation occurs in response to bac-
teria and pathogen-associated molecular patterns, result-
ing in iNOS transcription and nitric oxide production
[6,30]. Though this may be a direct effect of bacteria on
innate immune cells, nitric oxide may also be induced
by TNF-α binding to mTNFR1, which then activates a
Figure 5 Density of iNOS- and Iba1-positive cells in the normal
(grey bars) and bacteria-challenged (black bars) olfactory
mucosa (A). The density of iNOS-positive cells following bacterial
exposure is significantly more than that in the unperturbed olfactory
mucosa, increasing from 28± 2 to 129 ± 10 cells/mm mucosa. This
resulting high density of iNOS-positive cells is greater than the
density of Iba1-positive cells, indicating that a proportion of the
iNOS-positive cells are not macrophages. Error bars represent SEM.
**p< 0.01. The iNOS- and Iba1-positive cells are predominantly
located in the lamina propria (LP), close to the olfactory epithelium
(OE; B, C). In the normal, intact olfactory mucosa (D,E), Iba1-positive
cells can occasionally be observed in the olfactory epithelium (arrow
in E). Scale bar= 100 μm
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number of cellular pathways, including the activation
and nuclear translocation of NFκB [31,32]. NFκB activa-
tion also induces IL-6 transcription [33,34]. In our study,
a significant upregulation of TFN-α in olfactory tissues
at the 6-h time point preceded a significant upregulation
of IL-6 at the 24-h time point. A possible explanation is
that while TNF-α is produced to recruit factors that re-
move S. aureus, it also induces the production of IL-6.
In this study, at 24 h after bacterial infection, IL-6
immunoreactivity was present in supporting cells, olfac-
tory ensheathing cells, fibroblasts, endothelial cells and
innate immune cells. IL-6 has been previously shown to
be expressed by macrophages and olfactory ensheathing
cells [26,35] as well as endothelial cells and fibroblasts in
inflammatory conditions [36,37]. IL-6 mediates neutro-
phil responses (Dalrymple et al., 1995; Dalrymple et al.,
1996) and is also known to enhance neuron survival
(Toulmond et al., 1992; Loddick et al., 1998), and there-
fore may be neuroprotective with regard to olfactory
neuronal survival. Therefore, cytokines such as TNF-α
and IL-6 could work in synergy to maintain olfactory tis-
sue homeostasis while removing the bacterial infection.
Infiltration of bacteria in the primary olfactory pathway
This is the first study to show that bacteria in the nasal
cavity were able to reach the olfactory bulbs in as little
as 6 h. Previous studies had used longer time points to
assess bacterial invasion in the nasal connective tissue
and olfactory bulb [5,6]. In our study, S. aureus was
localised ultrastructurally to supporting cells of the ol-
factory epithelium, macrophages and a small number of
olfactory nerve bundles. Although previous studies have
indicated that olfactory ensheathing cells have anti-
bacterial properties by their expression of Toll-like
receptors (TLRs), nuclear translocation of nuclear factor
kappa B and production of nitric oxide in the presence
of bacteria [6,16,29], these mechanisms in combination
with macrophages of the lamina propria may not be en-
tirely effective in preventing infiltrating bacteria from
accessing the olfactory bulb. Therefore, under such cir-
cumstances, olfactory ensheathing cells could act as a
host for invading bacteria [38].
Mitral cells were the major population of cells in the
olfactory bulb showing immunoreactivity for IL-6, with
more diffuse staining in the external plexiform layer.
The immunostaining pattern suggests that the mitral cell
dendrites extending through the external plexiform layer
and terminating in the glomerular layer were stimulated
by S. aureus, which then induced upregulation of IL-6
expression. Previous studies involving intranasal inocula-
tion of mouse hepatitis virus revealed that viral RNA
could be detected in mitral cells 5 days after, eventually
resulting in a significant decrease in the mitral cell
population [39]. This suggested that mitral cells are vul-
nerable to infection from peripheral sources. Therefore,
expression of IL-6 may be upregulated in response to
bacteria as a protective mechanism to inhibit infection
of the cells.
Activation of microglia in the olfactory bulb
In this study the presence of S. aureus in the olfactory
nerve and glomerular layers was accompanied by the ap-
pearance of activated microglia throughout the olfactory
bulb, suggesting that although not in direct contact with
the pathogens, an intercellular sensing mechanism
induces rapid activation. A recent study has suggested
that olfactory bulb microglia may be distinct from
microglia from other parts of the CNS by having a lower
Figure 6 Density of iNOS- and Iba1-positive cells in the
olfactory nerve (ONL), glomerular (GmL) and granule layers
(GrL) in the unperturbed and bacterial challenged olfactory
bulbs (A). These layers show a significant increase in the number of
iNOS-positive cells in response to bacterial challenge (black bars)
compared to those in the untreated control olfactory bulb (grey
bars), 4.5 fold increase in the ONL+GmL and 2.8 fold increase in the
GrL. However there is no significant increase in the number of
Iba1-positive cells between the untreated olfactory bulb (bars with
vertical lines) and S. aureus-exposed olfactory bulb (bars with
horizontal lines). Error bars represent SEM. **p< 0.01. Fluorescence
microscopy shows activated microglia with hypertrophied cell
bodies and ramifying processes, and demonstrating co-localisation
of Iba1 and tomato lectin (TL) in S.aureus-exposed olfactory bulb
(B, C). Microglia (green: TL) expressing iNOS (red) in the vicinity of
the mitral cell layer (MCL) in S.aureus-exposed olfactory bulb (D). No
apparent staining for iNOS is observed in a similar area in this saline-
treated olfactory bulb (E). NY=Nuclear yellow; EPL= external
plexiform layer. Scale bar= 25 μm (B,C), 50 μm (D,E)
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activation threshold [40]. Lalancette-Hébert and co-
workers showed that following induction of focal cere-
bral ischemia by occlusion of the left middle cerebral
artery, a significant induction of TLR2 signals in micro-
glia of the olfactory bulbs was detected 6 h later, which
preceded any increase in TLR2 signals in and around
the ischaemic site. Furthermore, when lipopolysacchar-
ide, a component of gram-negative bacterial cell wall,
was injected into the nasal cavity, upregulation of TLR2
signals in the olfactory bulb, particularly in the glomeru-
lar layer, was similarly detected at 6 h, and this spread to
other parts of the brain by 24 h [40]. These observations
suggest that microglia of the olfactory bulbs have a more
alert, activated phenotype than microglia in the rest of
the CNS. Thus, they play a key role in the regulation of
inflammatory processes in the brain. In this regard, the
finding in our study that S. aureus was restricted to the
outer nerve and glomerular layers at 5 days after inocu-
lation is further support that the activated microglia of
the olfactory bulb have a role in neutralising bacterial
pathogens and are likely to be the key player that pre-
vents pathogens in the periphery of the olfactory bulb
from further migration into the CNS. In this regard, ol-
factory microglia clearly have a beneficial effect in safe-
guarding the CNS from harmful pathogens.
However, the immunomodulating property of olfactory
bulb microglia could act as a modifier of therapeutic
agents administered intranasally. Several studies have
shown the efficacy of the primary olfactory pathway as a
route of entry for growth factors and hormones into the
CNS [41-43]. Given their higher basal activity, it is pos-
sible that intranasally administered compounds, both
natural and synthetic, could trigger activation of olfac-
tory bulb microglia, thus releasing a host of molecules
including pro-inflammatory cytokines that have wide-
ranging effects not only on surrounding cells, but also
on the administered compound [44,45]. For example,
elevated secretory response from the microglia could
change the internalisation and transport, biodistribution
and perhaps ultimately the therapeutic potential of the
administered compound. Thus, the activity of olfactory
bulb microglia warrants further investigation, in terms of
their physiological role in protecting the brain from
pathogenic insults as well as their interaction with nas-
ally administered exogenous compounds.
Conclusions
Bacteria are able to penetrate the immunological defence
of the compromised olfactory mucosa and infiltrate the
olfactory bulb within 6 h even though a pro-inflammatory
profile is mounted. Activated microglia may have a role
in restricting bacteria to the outer layers of the olfactory
bulb. These findings have implications with regard to
susceptibility to CNS infections in the aftermath of dam-
age to the nasal lining.
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